Venture capital set records this year, and almost none of that money reached companies like yours, which is why the founders who keep moving are stacking two or three sources instead of chasing one.
Having been involved in dozens of startups, I almost never see a company reach its next milestone on money from a single source. The founders who keep moving treat capital like a supply chain and source each piece from whoever prices it best.
US investors deployed $412.7 billion into venture-backed companies in the first half of 2026, more than any full year on record and roughly 30% above all of 2025, according to the PitchBook-NVCA Venture Monitor. One layer down, the picture inverts. AI companies took 86% of those dollars, rounds of $100 million or more absorbed 87.5% of everything deployed, and seed-stage companies collectively raised $4.9 billion against $101 billion at late stage.
That is the real market. Record capital, historic concentration, and a seed environment that got tighter while the headlines got louder. If you are not training a frontier model, the top-line number is not your market and pitching as though it is will cost you a quarter.
Knowing how to fund a startup in 2026 means knowing which sources price your specific business correctly, then combining them. Below are ten that are actually funding companies right now, what each one costs in ownership or cash, and who each one fits.
The 2026 Funding Stack at a Glance
Start with the cheapest capital and work outward. Cheapest almost never means lowest interest rate. It means the least permanent claim on your company.
Funding source | Gives up equity | Typical size | Speed to cash | Best fit |
Revenue-based financing | No | $50K to $4M | 1 to 4 weeks | Recurring revenue, healthy gross margin |
Customer pre-sales | No | Varies | Days to weeks | Hardware, B2B SaaS with clear ROI |
Invoice and inventory financing | No | Tied to receivables | 1 to 3 weeks | Product and e-commerce businesses |
Federal and state grants | No | $50K to $2M per phase | 4 to 9 months | Deep tech, biotech, climate, defense |
SBA 7(a) and 504 loans | No | Up to $10M combined | 30 to 90 days | Operating businesses and acquisitions |
Convertible notes and SAFEs | Later | $100K to $3M | 2 to 6 weeks | Bridging to a priced round |
Online angel syndicates | Yes | $100K to $2M | 3 to 8 weeks | Pre-seed and seed with early traction |
Equity crowdfunding | Yes | Up to $5M per 12 months | 2 to 6 months | Consumer brands with a real community |
Corporate partners and CVC | Sometimes | Highly variable | 3 to 9 months | Products that plug into a large company |
Accelerators and local networks | Usually | $25K to $500K | 1 to 4 months | First-time founders needing structure |
Most healthy early-stage companies end up running two or three of these at once. Concentrating your entire balance sheet in one investor or one lender hands that party enormous leverage at exactly the moment you have none.
Non-Dilutive Capital: Keep the Whole Company
Non-dilutive money is any capital that does not take ownership. It still has a cost, and founders routinely underprice that cost because it does not show up on the cap table.
Revenue-Based Financing
You take a lump sum and repay it as a fixed share of monthly revenue until you hit a predetermined cap. Payments rise in strong months and fall in weak ones, which is the feature founders buy.
Terms in 2026 cluster around a repayment cap of 1.2x to 1.5x on shorter facilities and stretch to 2.5x on multi-year deals, with a revenue share of roughly 2% to 10% per month. The trap is that the cap is not an interest rate. Repay a 1.4x facility in nine months and your effective annualized cost lands well north of 40%, so speed of repayment works against you, not for you.
Read the contract for the definition of revenue, any minimum monthly payment, and the pause threshold. A minimum payment quietly converts your flexible instrument into a term loan the first quarter sales slip. Revenue-based financing fits SaaS, subscription, and e-commerce businesses with predictable revenue and gross margins above roughly 50%. It does nothing for pre-revenue companies.
Customer Pre-Sales and Prepaid Contracts
Getting customers to pay in advance is the only funding source that validates demand and finances it in the same transaction. Annual prepay in exchange for a discount, multi-year deals with the first year up front, or deposits on hardware all move cash from your future to your present at zero dilution.
The discount is your interest rate. Trading 20% off an annual contract for cash today is roughly a 20% cost of capital on a one-year term, which beats most alternatives on this list and beats every equity option. Structure the deal so the discount buys a commitment, not just timing, and read our breakdown of funding growth through customer prepayments before you price it.
The obligation is real, though. Prepaid revenue is a delivery promise on your balance sheet, and spending it on payroll before you can deliver is how otherwise healthy companies end up insolvent on paper.
Invoice, Inventory, and Purchase-Order Financing
Lenders advance cash against receivables, inventory, or purchase orders from creditworthy customers. This is the right tool when you are growing faster than your cash conversion cycle, which is the specific problem that kills profitable product businesses.
Pricing is usually quoted as a discount rate per 30 days, which makes annualized cost easy to underestimate. A 2% fee per 30 days on a 60-day receivable is roughly 25% annualized. Your customer’s credit quality drives approval more than yours does, so a few strong enterprise accounts can unlock capital that your own business credit profile would not.
Federal and State Grants
Grant capital is back after an unusual interruption. Congressional authorization for the SBIR and STTR programs lapsed on October 1, 2025, freezing new solicitations across 11 federal agencies for nearly six months. The Small Business Innovation and Economic Security Act was signed on April 13, 2026, reauthorizing both programs through September 30, 2031.
The reauthorized programs are not identical to the old ones. There is a new Phase II vehicle for strategic breakthrough work with a $30 million ceiling, materially expanded screening of foreign affiliations and investment ties, and, starting in fiscal 2027, agency-set caps on how many proposals a single company can submit. That last change is aimed at serial applicants who built businesses on grant revenue, so if that describes you, plan for it now.
Grants fit deep tech, biotech, climate, defense, and advanced manufacturing, and they take four to nine months from solicitation to cash. Cloud credits stack on top, with a caveat most founders learn late: self-serve tiers from the major providers run about $1,000 to $5,000, while the six-figure tiers require nomination by a VC or accelerator. Credits are also not cash. They cut burn at one vendor and quietly build switching costs.
SBA 7(a) and 504 Loans
The option most startup funding guides skip is the one that moved the most in 2026. Effective July 4, 2026, the SBA doubled the combined 7(a) and 504 cap to $10 million, giving borrowers two independent $5 million ceilings instead of one shared limit. The 7(a) covers working capital, inventory, and goodwill in an acquisition, while the 504 covers owner-occupied real estate and heavy equipment.
Maximum 7(a) rates run roughly 9.75% to 14.75% depending on loan size and term, built off a base rate plus a capped lender markup, with prime at 6.75% as of July 2026. Compare that against a 1.4x revenue-based facility repaid in a year and the bank looks cheap.
Two constraints matter. A rule effective March 1, 2026 requires 100% US citizen or national ownership, with no exception for minority stakes, and lenders reported a steep drop in 7(a) volume in the months that followed. Personal guarantees are standard, and most lenders want two years of operating history, which puts this squarely in the debt side of the debt versus equity decision for operating businesses rather than pre-revenue startups.
Hybrid Capital: Debt Today, Equity Later
Convertible Notes and SAFEs
Correct one thing before you sign either document. A SAFE is not debt. It carries no interest, no maturity date, and no repayment obligation, which is exactly why founders like it. A convertible note is debt: it accrues interest, it matures, and the holder can demand repayment on a date certain.
The post-money SAFE has been the market standard since 2018, and its mechanics are where founders get hurt. A post-money SAFE fixes the investor’s ownership percentage as a share of the company after the SAFE round closes, so every additional SAFE you sell dilutes you and not the earlier SAFE holders. Sell four of them at different caps across eighteen months and the priced round math frequently lands 25% to 35% below what the founders penciled.
Model the conversion before you take the money, not after the term sheet arrives. Both instruments are the right call when you are bridging to a defined milestone and do not want to set a valuation today. Both are the wrong call when you are using them to avoid a valuation conversation you will lose anyway.
Venture debt is the adjacent option here, and it is bifurcating like everything else. Lenders wrote $64.7 billion across 280 loans in the first half of 2026, with a handful of enormous infrastructure facilities on one end and limited access on the other.
Friends, Family, and Private Lenders
The same instruments show up when the check comes from someone at Thanksgiving. The paperwork should not get lighter because the relationship is closer, and in my experience it usually does. Price it, document it, and set expectations about total loss in writing, which is the whole argument in our guide to raising friends and family money without regret.
Dilutive Capital: Selling Equity on Purpose
Online Angel Syndicates
Syndicates pool individual angels and small groups into a single line on your cap table, led by someone who has done diligence. You get sophisticated early-stage money with less process than an institutional round and a cleaner cap table than twenty individual checks.
Traction is the entry ticket. Lead quality matters more than platform, because the lead sets terms, brings the followers, and either does or does not show up for the next round. Our guide to angel networks, syndicates, and platforms covers how to tell them apart, and if you want the other side of the table, the red flags angels look for in pitches will save you a cycle.
Equity Crowdfunding
Regulation Crowdfunding lets you raise up to $5 million in a rolling 12-month period from accredited and non-accredited investors through a registered portal. The cap is not the number to plan around. SEC data through 2024 puts the average successful raise at roughly $346,000, a fraction of the ceiling.
Know the mechanics before you commit six months to it. First-time issuers raising $1,235,000 or more need audited financials, advertising outside the portal is restricted to tombstone details, and SEC guidance issued in February 2026 confirmed an offering runs on one platform at a time. Switching platforms means canceling, removing your materials, and filing a fresh Form C.
Consumer brands with an engaged community win here. Everyone else pays real money to discover that a crowdfunding raise is a marketing campaign with securities filings attached.
Strategic Corporate Partnerships and Corporate Venture
Corporate money has never been more concentrated. Corporate investors accounted for a record 87.9% of US AI venture deal value in 2026 so far, while participating in a shrinking share of deals overall. Outside AI, the corporate check has gotten harder to land and slower to close.
Where it works, it works well. A pilot with revenue attached, distribution through an existing sales force, or committed volume from a strategic partner is worth more than the check itself. Watch for terms that quietly foreclose your future: exclusivity, rights of first refusal on an acquisition, or most-favored-nation pricing will each shrink your buyer pool later.
Accelerators, Competitions, and Local Investor Networks
Accelerator economics are what they always were. You trade 5% to 7% for capital, structure, and a demo day, and the value is concentrated in the network and the follow-on access rather than the cash. A growing number of programs now offer non-dilutive prizes, credits, or in-kind support instead, which is worth seeking out if you already have distribution figured out.
Local angel groups, industry investment clubs, and rolling funds close faster than institutional processes because the relationship predates the pitch. These investors also tend to understand your market, which means less time educating and more time diligencing. Regional capital rarely shows up in national funding data, and it is funding a great many companies that never appear in a PitchBook chart.
How to Choose the Right Funding Approach
Answer four questions honestly and the list narrows fast.
- How much ownership do you want to keep? If dilution is painful today, start with revenue-based financing, grants, pre-sales, and SBA debt before you talk to a single investor.
- What does your cash flow actually look like? Predictable revenue opens revenue-based financing and receivables lending. Lumpy or pre-revenue pushes you toward grants, angels, and pre-sales.
- What milestone are you funding? Product development fits grants and SAFEs. Go-to-market, inventory, and working capital fit revenue-based or supply-chain financing.
- How fast do you need it? Customer advances can land in days. Grants and crowdfunding take months, and a raise that closes after your runway ends is not funding, it is a story.
The stack most operators land on is some non-dilutive base, usually grants plus prepayments or a revenue facility, topped with a smaller equity or convertible raise that adds strategic investors and extends runway.
What Actually Kills Funding Rounds
Clean numbers close deals. Investors and lenders both underwrite unit economics, gross margin, and realistic runway, and messy books kill more rounds than weak decks do. If you cannot produce your LTV to CAC ratio on demand, you are not ready to ask for money.
Treat every source as a relationship that outlives the transaction. Capital providers talk to each other, and the founder who ran a disciplined process becomes the founder who gets a warm intro to the next one. Consistent investor updates do more for your next raise than any single pitch meeting.
Set your walk-away points before you need the money. Decide the maximum dilution and the maximum repayment multiple you will accept while you still have six months of runway, because desperation is visible in a term sheet negotiation and it gets priced in. Keep shipping and keep talking to customers while you raise, since the companies that close fastest are the ones whose metrics moved during the process.
Where This Leaves You
The concentration at the top of the venture market is structural, not a phase, and the founders who plan around it will out-execute the ones waiting for the market to normalize. Pull your last twelve months of revenue, your gross margin, and your cash conversion cycle this week, then map them against the table above and identify the two sources that price your business correctly.
Then go get the cheapest one first.
